Cite
Anti-Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)-Derived Mouse Strain.
MLA
McInerney, Marcia F., et al. “Anti-Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)-Derived Mouse Strain.” Experimental Diabetes Research, vol. 5, no. 3, Sept. 2004, pp. 177–85. EBSCOhost, https://doi.org/10.1080/15438600490478029.
APA
McInerney, M. F., Najjar, S. M., Brickley, D., Lutzke, M., Abou-Rjaily, G. A., Reifsnyder, P., Haskell, B. D., Flurkey, K., Zhang, Y.-J., Pietropaolo, S. L., Pietropaolo, M., Byers, J. P., & Leiter, E. H. (2004). Anti-Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)-Derived Mouse Strain. Experimental Diabetes Research, 5(3), 177–185. https://doi.org/10.1080/15438600490478029
Chicago
McInerney, Marcia F., Sonia M. Najjar, Deanna Brickley, Mary Lutzke, George A. Abou-Rjaily, Peter Reifsnyder, Bradford D. Haskell, et al. 2004. “Anti-Insulin Receptor Autoantibodies Are Not Required for Type 2 Diabetes Pathogenesis in NZL/Lt Mice, a New Zealand Obese (NZO)-Derived Mouse Strain.” Experimental Diabetes Research 5 (3): 177–85. doi:10.1080/15438600490478029.